Sanai Health Industry Group Co (FRA:WUP0) Current Ratio: 3.59 (As of Dec. 2025) — 41% Above Median

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

FRA:WUP0 Sanai Health Industry Group Co Ltd FRA:WUP0
40 GF Score
Price €0.03
GF Value €0.05
! 5 Warning Signs
View Full Analysis

What is Sanai Health Industry Group Co Current Ratio?

Sanai Health Industry Group Co FRA:WUP0 40 Current Ratio is 3.59 as of Dec. 2025, which is 41% above its 10-year median of 2.54. GuruFocus rates FRA:WUP0 with a GF Score™ of 40/100 and a GF Value™ of €0.05. The stock has 5 warning signs investors should review. Among 1,000 Drug Manufacturers companies, Sanai Health Industry Group Co ranks better than 74.2% on this metric.

The current ratio is a liquidity ratio that measures a company's ability to pay short-term obligations. It is calculated as a company's Total Current Assets divides by its Total Current Liabilities. Sanai Health Industry Group Co's current ratio for the quarter that ended in Dec. 2025 was 3.59.

Sanai Health Industry Group Co has a current ratio of 3.59. It indicates the company may not be efficiently using its current assets or its short-term financing facilities. This may also indicate problems in working capital management.

The historical rank and industry rank for Sanai Health Industry Group Co's Current Ratio or its related term are showing as below:

FRA:WUP0' s Current Ratio Range Over the Past 10 Years
Min: 0.83   Med: 2.54   Max: 3.59
Current: 3.59

During the past 13 years, Sanai Health Industry Group Co's highest Current Ratio was 3.59. The lowest was 0.83. And the median was 2.54.

FRA:WUP0's Current Ratio is ranked better than
74.2% of 1000 companies
in the Drug Manufacturers industry
Industry Median: 2 vs FRA:WUP0: 3.59

Sanai Health Industry Group Co  (FRA:WUP0) Current Ratio Explanation

The current ratio can give a sense of the efficiency of a company's operating cycle or its ability to turn its product into cash. Companies that have trouble getting paid on their receivables or have long inventory turnover can run into liquidity problems because they are unable to alleviate their obligations. Because business operations differ in each industry, it is always more useful to compare companies within the same industry.

Acceptable current ratios vary from industry to industry and are generally between 1 and 3 for healthy businesses.

The higher the current ratio, the more capable the company is of paying its obligations. A ratio under 1 suggests that the company would be unable to pay off its obligations if they came due at that point. While this shows the company is not in good financial health, it does not necessarily mean that it will go bankrupt - as there are many ways to access financing - but it is definitely not a good sign.

If all other things were equal, a creditor, who is expecting to be paid in the next 12 months, would consider a high current ratio to be better than a low current ratio, because a high current ratio means that the company is more likely to meet its liabilities which fall due in the next 12 months.


Sanai Health Industry Group Co Current Ratio Related Terms


Sanai Health Industry Group Co Current Ratio Historical Data

* Premium members only.

The historical data trend for Sanai Health Industry Group Co's Current Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Sanai Health Industry Group Co Current Ratio Chart

Sanai Health Industry Group Co Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Current Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 2.10 2.82 3.28 3.20 3.59

Sanai Health Industry Group Co Semi-Annual Data
Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Current Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 3.28 4.21 3.20 2.64 3.59

FRA:WUP0 vs ZTS, UTHR, VTRS: Current Ratio Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Sanai Health Industry Group Co's Current Ratio, along with its competitors' market caps and Current Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Sanai Health Industry Group Co Current Ratio vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Sanai Health Industry Group Co's Current Ratio distribution charts can be found below:

* The bar in red indicates where Sanai Health Industry Group Co's Current Ratio falls into.


FRA:WUP0
40GF Score
Sanai Health Industry Group Co Ltd FRA:WUP0
Current Ratio is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Sanai Health Industry Group Co Current Ratio Calculation

The current ratio is mainly used to give an idea of the company's ability to pay back its short-term liabilities with its short-term assets.

Sanai Health Industry Group Co's Current Ratio for the fiscal year that ended in Dec. 2025 is calculated as

Current Ratio (A: Dec. 2025 )=Total Current Assets (A: Dec. 2025 )/Total Current Liabilities (A: Dec. 2025 )
=41.673/11.593
=3.59

Sanai Health Industry Group Co's Current Ratio for the quarter that ended in Dec. 2025 is calculated as

Current Ratio (Q: Dec. 2025 )=Total Current Assets (Q: Dec. 2025 )/Total Current Liabilities (Q: Dec. 2025 )
=41.673/11.593
=3.59

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Current Ratio →
What does a Current Ratio of 3.59 mean?
Sanai Health Industry Group Co (FRA:WUP0) has a Current Ratio of 3.59 as of Dec. 2025. This is 41% above median its historical median of 2.54. Over the past decade, Sanai Health Industry Group Co's Current Ratio has ranged from 0.83 to 3.59. According to the industry distribution chart, Sanai Health Industry Group Co ranks #258 out of 1000 companies in the Drug Manufacturers industry, placing it in the top 25.8%.
Is Sanai Health Industry Group Co's Current Ratio too high?
Sanai Health Industry Group Co's current Current Ratio of 3.59 is 41% above median its 10-year median of 2.54. Over the past 10 years, this metric has ranged from a low of 0.83 to a high of 3.59. The Drug Manufacturers industry median Current Ratio is 2.00. Sanai Health Industry Group Co's value of 3.59 is 79.5% above this industry median. Based on the distribution chart, Sanai Health Industry Group Co ranks #258 out of 1000 companies in the Drug Manufacturers industry, which is above the industry midpoint. Overall, Sanai Health Industry Group Co has a GF Score™ of 40/100, reflecting its overall financial health beyond just this single metric.
How does Sanai Health Industry Group Co's Current Ratio compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, Sanai Health Industry Group Co ranks #258 out of 1000 companies for Current Ratio. This puts Sanai Health Industry Group Co in the upper half of its industry. The industry median Current Ratio is 2.00. Sanai Health Industry Group Co's value of 3.59 is 79.5% above this benchmark. Historically, Sanai Health Industry Group Co's own Current Ratio has ranged from 0.83 to 3.59 over the past decade. While the company's 10-year median is 2.54 vs. the industry median of 2.00, Sanai Health Industry Group Co has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Current Ratio for a Drug Manufacturers company?
The median Current Ratio among Drug Manufacturers companies is 2.00, based on 1,000 companies in the industry. Companies in the top quartile (top 25%) have a Current Ratio significantly above this median, while those in the bottom quartile fall well below. However, Current Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Sanai Health Industry Group Co's current Current Ratio of 3.59 is 79.5% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Current Ratio mean?
A high Current Ratio can signal that a stock is expensive relative to its fundamentals. For the Drug Manufacturers industry, the median Current Ratio is 2.00 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Sanai Health Industry Group Co's current Current Ratio is 3.59, which is 41% above median its own 10-year median of 2.54. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Sanai Health Industry Group Co stock overvalued right now?
Sanai Health Industry Group Co (FRA:WUP0) has a current Current Ratio of 3.59. The stock's GF Value™ is €0.05, compared to a current price of €0.03 — trading 50% below its estimated fair value. The current Current Ratio is 3.59, which is 41% above median its 10-year median of 2.54 and 79.5% above the Drug Manufacturers industry median of 2.00. Sanai Health Industry Group Co's overall GF Score™ is 40/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Current Ratio calculated?
Current Ratio is calculated from a company's financial statements. For Sanai Health Industry Group Co (FRA:WUP0), the current Current Ratio is 3.59 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Sanai Health Industry Group Co (FRA:WUP0) Overvalued in 2026?

Based on GuruFocus' analysis, Sanai Health Industry Group Co stock appears to be undervalued. The current stock price of €0.03 is trading 50% below its estimated GF Value™ of €0.05.

Key valuation signals for FRA:WUP0:

  • Current Ratio: 3.59 (41% above median its 10-year median of 2.54)
  • GF Value™: €0.05 vs. price of €0.03 (50% below fair value)
  • GF Score™: 40/100 with 5 warning signs
  • Industry Position: 79.5% above the Drug Manufacturers median (#258 of 1000)

No single metric tells the full story. See the FRA:WUP0 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Sanai Health Industry Group Co Business Description

Other Exchanges 01889:Hong Kong
Address 57 Hung To Road, Unit 5, 7th Floor, Nanyang Plaza, Kwun Tong, Kowloon, Hong Kong, HKG
Sanai Health Industry Group Co Ltd is a pharmaceutical company. The company has three reportable segments namely Pharmaceutical products include development, manufacturing, marketing, and sales of pharmaceutical products and related software and provision of consultancy services. Finance leasing includes the provision of financial leasing services; Genetic testing and molecular diagnostic services segment. It generates maximum revenue from Pharmaceutical products segments. Geographically, it derives the majority of its revenue from the PRC.
40GF Score

Get the complete analysis for FRA:WUP0

Current Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€0.03
Price
€0.05
GF Value